Fenbufen NEW
| Price | $29 |
| Package | 1mL |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-06-17 |
Product Details
| Product Name: Fenbufen | CAS No.: 36330-85-5 |
| Purity: 98.46% | Supply Ability: 10g |
| Release date: 2025/06/17 |
Product Introduction
Bioactivity
| Name | Fenbufen |
| Description | Fenbufen (Lederfen) is a non-steroidal anti-inflammatory drug used primarily to treat inflammation in osteoarthritis, ankylosing spondylitis, and tendinitis. It can also be used to relieve backaches, sprains, and fractures. Fenbufen is available as a capsule or tablet sold with the brand names Cepal, Cinopal, Cybufen, Lederfen, and Reugast. Fenbufen acts by preventing cyclooxygenase from producing prostaglandins which can cause inflammation. |
| In vivo | Fenbufen and its metabolites could be involved in mitochondrial toxicity through inhibition of ATP synthesis[1]. Fenbufen inhibited prostaglandin release by 80% and reduced rates of protein synthesis in normal muscle and in muscle undergoing hypertrophy in response to tenotomy of a synergist[3]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | Ethanol : 47 mg/mL (184.84 mM), Sonication is recommended. DMSO : 47 mg/mL (184.84 mM), Sonication is recommended. H2O : < 1 mg/mL (insoluble or slightly soluble) |
| Keywords | tendinitis | osteoarthritis | Inhibitor | inhibit | Fenbufen | Cyclooxygenase | COX | CL82204 | CL 82204 | Caspase | ATP systhesis | antirheumatic | antipyretic | anti-inflammatory | ankylosing spondylitis | analgetic |
| Inhibitors Related | Sodium oleate | Acetaminophen | Aspirin | Salicylamide | Gallic Acid Monohydrate | Diclofenac Potassium | Meloxicam | Paradol | Salicylic acid | Phenylbutazone | Glafenine | Revaprazan hydrochloride |
| Related Compound Libraries | Apoptosis Compound Library | Pain-Related Compound Library | Bioactive Compound Library | Membrane Protein-targeted Compound Library | Drug Repurposing Compound Library | Inhibitor Library | Anti-Cancer Approved Drug Library | Anti-Aging Compound Library | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max | Anti-COVID-19 Compound Library | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
![6-Bromopyrazolo[3,4-d]pyrimidin-4(5H)-one](https://img.chemicalbook.com/ProductImageEN1/2025-04/Large/5f34c688-a929-4155-8317-2cb69c189189.png)
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $29.00/1mL |
VIP5Y
|
TargetMol Chemicals Inc.
|
2025-06-17 | |
| $29.00/1mL |
VIP1Y
|
TargetMol Chemicals Inc.
|
2025-04-28 | |
| $1.90/1KG |
VIP5Y
|
Hebei Chuanghai Biotechnology Co,.LTD
|
2024-08-20 | |
| $100.00/1kg |
Liaoning Pharmaceutical Innovation Co., Ltd
|
2024-03-06 | ||
| $66.00/1KG |
Xiamen Wonderful Bio Technology Co., Ltd.
|
2023-07-21 | ||
| $0.00/1kg |
VIP5Y
|
WUHAN FORTUNA CHEMICAL CO., LTD
|
2022-06-02 | |
| $90.00/1KG |
Hebei baicao biology science and technology co., ltd
|
2022-05-06 | ||
| $1.10/1g |
VIP5Y
|
Dideu Industries Group Limited
|
2021-06-15 | |
| $20.00/1KG |
Longyan Tianhua Biological Technology Co., Ltd
|
2020-11-14 | ||
| $1.00/25Kg/Drum |
HubeiwidelychemicaltechnologyCo.,Ltd
|
2019-10-29 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY